Journal of Structural Chemistry. Vol. 52, No. 4, pp. 809-812, 2011
Original Russian Text Copyright © 2011 by A. D. Vasiliev and N. N. Golovnev
2+
2−
4
CRYSTAL STRUCTURE OF C17H20FN3O ⋅CuBr ⋅H2O
3
© A. D. Vasiliev and N. N. Golovnev
UDC 548.737
2+
2−
A new compound C H FN O ⋅CuBr ⋅H O is synthesized in the crystal form, where C H FN O
17 20 3 2 17 18 3 3
3
4
(CfH, ciprofloxacin) is 4-oxo-7-(1-piperazinyl)-6-fluoro-1-cyclopropyl-1,4-dihydroquinoline-3-carboxylic
acid. Crystallographic data of ciprofloxacinium tetrabromocuprate(II) monohydrate, C H Br CuFN O :
17 22
4
3
4
a = 8.214(1) Å, b = 10.781(2) Å, с = 13.703(2) Å, α = 85.144(2)°, β = 79.119(2)°, γ = 84.018(2)°, V =
3
1182.5(4) Å , P1 space group, Z = 2. Supramolecular architecture of the crystal differs from that
2+
2−
established for C H FN O ⋅CuCl ⋅H O by the absence of π–π interactions of the aromatic rings of
17 20 3 2
3
4
2+
CfH ions and also the structural motifs formed by intermolecular hydrogen bonds.
3
Keywords: fluoroquinolones, ciprofloxacin, bromide, copper(II), crystal structure, hydrogen bonds.
Fluoroquinolones have recently aroused considerable interest of the scientific society because of practical and
fundamental aspects. In crystal design, hydrogen bonds are considered as key supramolecular interactions. The development
of the concept of supramolecular synthons allows the crystals to be classified and presented in the form of supramolecular
units [1, 2]. Intermolecular π–π interactions of aromatic rings can also play an important role in the antibacterial activity of
fluoroquinolones. One of the most effective representatives of fluoroquinolones is ciprofloxacin (CfH), C H FN O —
17 18
3
3
4-oxo-7-(1-piperazinyl)-6-fluoro-1-cyclopropyl-1,4-dihydroquinoline-3-carboxylic acid, which determines its comprehensive
2+
study [3]. The structures of ionic ciprofloxacin compounds containing the CfH cation are the least studied [4]. We have
3
2+
2−
previously established the structure of C H FN O ⋅CuCl ⋅H O [5]. In order to systematically investigate the effect of the
17 20 3 2
3
4
2+
2−
nature of a halide ligand on crystal packing and its structural motifs, a new compound C H FN O ⋅CuBr ⋅H O (I) was
17 20 3 2
3
4
synthesized (C H CuBr FN O , ciprofloxacinium tetrabromocuprate(II) monohydrate — CfH [CuBr ]⋅H O) and its crystal
18 22 4 3 3 2
4
4
and molecular structure was determined.
Experimental. CfH in the form of white powder was isolated on storing or heating in air of an ammonia solution of
ciprofloxacinium chloride monohydrate CfH⋅HCl⋅H O (Ranbaxia, India) with pH 11-12 to pH 8. It was filtered off, several
2
times washed with distilled water and dried in air to constant weight.
Synthesis of C H FN O ⋅CuBr2− ⋅H O. 0.30 g of ciprofloxacin were dissolved in 3 ml of 7M HBr; then to the
2+
17 20
3
2
3
4
obtained solution CuO (chemically pure) was slowly added to the molar ratio CuO:CfH = 2:1. Black crystals of the
compound were isolated on evaporation of the solution. When selecting the medium acidity, we were guided by the data on
CfH protonation in strongly acidic solutions [6].
For the structural study we chose a crystal with the dimensions of 0.36×0.18×0.08 mm. Reflection intensities were
measured on a single crystal X-ray SMART APEX II diffractometer equipped with a CCD detector (Bruker AXS), MoK
α
radiation. Experimental absorption corrections were taken into account in the SADABS program [7] by the multi-scan
Siberian Federal University, Krasnoyarsk; ngolovnev@sfu-kras.ru. Translated from Zhurnal Strukturnoi Khimii,
Vol. 52, No. 4, pp. 829-832, July-August, 2011. Original article submitted October 29, 2010.
0022-4766/11/5204-0809
809